Online inquiry

IVTScrip™ mRNA-Human ADGRG1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK10741MR)

This product GTTS-WK10741MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ADGRG1 protein. This product can be used in CD4+ cytotoxic T cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001145770.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 9289
UniProt ID Q9Y653
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ADGRG1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK10741MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK21390MR IVTScrip™ mRNA-Human Albumin, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA Albumin
GTTS-WK2235MR IVTScrip™ mRNA-Human CD9, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA CD9
GTTS-WK12501MR IVTScrip™ mRNA-Human ADAMTS17, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ADAMTS17
GTTS-WK18969MR IVTScrip™ mRNA-Human AKIRIN1, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA AKIRIN1
GTTS-WK18599MR IVTScrip™ mRNA-Human APBB1IP, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA APBB1IP
GTTS-WK7444MR IVTScrip™ mRNA-Human ADGRG6, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ADGRG6
GTTS-WK13159MR IVTScrip™ mRNA-Human ADORA2A, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ADORA2A
GTTS-WK20038MR IVTScrip™ mRNA-Human ANKS3, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ANKS3
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →